PYOTT DAVID E I Insider Trading Activity

Average Profitability
18.82%
Insider Buys Quantity
3
Insider Buys Sum
$3.44M
Insider Sells Quantity
14
Insider Sells Sum
$24.64M

Insider Activity of PYOTT DAVID E I

According to the SEC Form 4 filings, PYOTT DAVID E I, being in a position of

  1. director at Alnylam Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 7440 shares for $2.22M,
    over all time since 2016-10-13, has bought 55800 shares for $2.06M, and sold 39890 shares for $9.39M.

Biography of PYOTT DAVID E I

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $2,224,5601100

Comparison of Insiders on Amount of Buys and Sells

2025-11-14SaleSylvamo Corporation
SLVM
VP, Controller,Chief Acct.Off.
1,000
0.0024%
$45.77$45,770+1.51%
2025-11-14SaleUniversal Electronics Inc.
UEIC
EVP Global Sales
559
0.0042%
$2.96$1,657+0.17%
2025-11-13SaleACRES Commercial Realty Corp.
ACR
10 percent owner
733
–
$25.15$18,435-14.71%
2025-11-13PurchaseAudioEye, Inc.
AEYE
director
6,000
0.0487%
$11.90$71,420-0.87%
2025-11-13SaleAmalgamated Financial Corp.
AMAL
EVP, Chief Legal Officer
3,425
0.0114%
$27.76$95,078+0.4%
2025-11-13SaleA-Mark Precious Metals, Inc.
AMRK
Chief Executive Officer
16,000
0.0665%
$26.04$416,592-2.33%
2025-11-13SaleArtivion, Inc.
AORT
SVP, Clinical & MD Affair
4,993
0.0106%
$45.86$228,969-0.71%
2025-11-13SaleArtivion, Inc.
AORT
SVP, General Counsel
5,761
0.0122%
$45.86$264,188-0.71%
2025-11-13SaleArtivion, Inc.
AORT
Chief Commercial Officer
6,563
0.014%
$45.86$300,966-0.71%
2025-11-13SaleArtivion, Inc.
AORT
President & CEO
34,210
0.0727%
$45.86$1.57M-0.71%
2025-11-13SaleApogee Therapeutics, Inc.
APGE
Chief Executive Officer
20,000
0.0365%
$63.01$1.26M-0.07%
2025-11-13SaleAXT, Inc.
AXTI
CFO
101,297
0.2133%
$10.14$1.03M+2.98%
2025-11-13PurchaseSaul Centers, Inc.
BFS
Senior Vice President & CFO
450
–
$20.60$9,270+45.15%
2025-11-13SaleBioLife Solutions, Inc.
BLFS
President and CEO
31,165
0.0652%
$25.33$789,409-0.75%
2025-11-13SaleChubb Limited
CB
Executive Vice President and*
5,830
0.0015%
$297.08$1.73M-0.28%
2025-11-13PurchaseCPS Technologies Corporation
CPSH
director
1,500
0.0104%
$3.42$5,127-0.52%
2025-11-13SaleCastellum, Inc.
CTM
General Counsel, Secretary
160,000
0.1677%
$1.17$186,400+0.86%
2025-11-13PurchaseDonegal Group Inc.
DGICA
10 percent owner
29,000
0.0796%
$19.53$566,300+1.86%
2025-11-13SaleDonegal Group Inc.
DGICA
SVP & GENERAL COUNSEL
900
0.0025%
$19.74$17,762+0.78%
2025-11-13SaleDonegal Group Inc.
DGICA
director
4,500
0.0125%
$19.73$88,767+0.83%
Total: 828855
*Some uncertain data for Preferred Stock share type transactions are shown in italics; for actual data please follow the link
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.